Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies
The DOI matches its Crossref record; 423 of the 423 references it cites were found in a registry or an index.
Abstract
Continuously increasing understanding of the molecular triggers responsible for the onset of diseases, paralleled by an equally dynamic evolution of chemical synthesis and screening methods, offers an abundance of pharmacological agents with a potential to become new successful drugs. However, before patients can benefit of newly developed pharmaceuticals, stringent safety filters need to be applied to weed out unfavourable drug candidates. Cost effectiveness and the need to identify compound liabilities, without exposing humans to unnecessary risks, has stimulated the shift of the safety studies to the earliest stages of drug discovery and development. In this regard, in vivo relevant organotypic in vitro models have high potential to revolutionize the preclinical safety testing. They can enable automation of the process, to match the requirements of high-throughput screening approaches, while satisfying ethical considerations. Cultures of primary hepatocytes became already an inherent part of the preclinical pharmaco-toxicological testing battery, yet their routine use, particularly for long-term assays, is limited by the progressive deterioration of liver-specific features. The availability of suitable hepatic and other organ-specific in vitro models is, however, of paramount importance in the light of changing European legal regulations in the field of chemical compounds of different origin, which gradually restrict the use of animal studies for safety assessment, as curr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased albumin secretion from spheroids compared to cell monolayers, as seen here, is consistent with observations reported in literature, which indicates that culturing the cells as spheroids may enhance homotypic cell-cell interactions within aggregated hepatocytes and improve functional outcomes of the hepatic construct [25,48].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [48]
In the citing paper
“Increased albumin secretion from spheroids compared to cell monolayers, as seen here, is consistent with observations reported in literature, which indicates that culturing the cells as spheroids may enhance homotypic cell-cell interactions within aggregated hepatocytes and improve functional outcomes of the hepatic construct [25,48].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [48]
In the citing paper
“Although scarcely distributed, the ECM is an integral part of the complex liver architecture and the restoration of cell-ECM contacts is crucial for the preservation of the differentiated hepatic phenotype in cell culture (Fraczek et al., 2013[12]; Ye et al., 2019[48]).”
From Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-matrigel matrices (2023) · cites this paper as Fraczek et al., 2013[12]
In the citing paper
“The application of primary human hepatocytes following isolation from human tissue is well accepted to be compromised by the process of dedifferentiation.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Fraczek et al. 2013
In the citing paper
“HNF1α, C/EBP and HNF1β were amongst the most significantly associated regulators with the loss of metabolic competence.”
From Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile (2017) · cites this paper as Fraczek et al. 2013
Citations
Cites
1 retracted
Items 201–400 of 423
Edwards, A., Glistak, M. L., Lucas, C. M., & Wilson, P. A. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90425-8 · Cited by 99 · cited 1×
“These effects were partially mediated by stimulating gene expression and partially by decreasing protein degradation (Villa et al. 1980; Edwards et al. 1984).”
BackgroundInoue, C., Yamamoto, H., Nakamura, T., Ichihara, A., & Okamoto, H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83650-x · Cited by 97
Small noncoding RNAs: Biogenesis, function, and emerging significance in toxicology
Choudhuri, S. (2010) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.20325 · Cited by 97
The unit-concept of hepatic parenchyma--a re-examination based on angioarchitectural studies.
Matsumoto, T., & Kawakami, M. (1982) · PubMed · Cited by 96
Ban, N., Yamada, Y., Someya, Y., Miyawaki, K., Ihara, Y., Hosokawa, M., Toyokuni, S., Tsuda, K., & Seino, Y. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1409 · Cited by 95
Role of the Liver-Enriched Transcription Factor HNF-1α in Expression of the CYP2E1 Gene
Liu, S., & Gonzalez, F. J. (1995) · DNA and Cell Biology · doi:10.1089/dna.1995.14.285 · Cited by 95
Liver enriched transcription factors and differentiation of hepatocellular carcinoma.
Hayashi, Y., Wang, W., Ninomiya, T., Nagano, H., Ohta, K., & Itoh, H. (1999) · Molecular Pathology · doi:10.1136/mp.52.1.19 · Cited by 95
Rojkind, M., Novikoff, P. M., Greenwel, P., Rubin, J. B., Rojas-Valencia, L., de Carvalho, A. C. C., Stockert, R. J., Spray, D. C., Hertzberg, E. L., & Wolkoff, A. W. (1995) · PubMed Central · Cited by 94
Characterization of the Human Cytochrome P4502D6 Promoter
Cairns, W., Smith, C. D., McLaren, A. W., & Wolf, C. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25269 · Cited by 94
van de Bovenkamp, M., Groothuis, G. M. M., Draaisma, A. L., Merema, M. T., Bezuijen, J. I., van Gils, M. J., Meijer, D. K. F., Friedman, S. L., & Olinga, P. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi127 · Cited by 94
Transcriptional control of the rat hepatic CYP2E1 gene.
Ueno, T., & Gonzalez, F. J. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.9.4495 · Cited by 93
Corlu, A., Kneip, B., Lhadi, C., Leray, G., Glaise, D., Baffet, G., Bourel, D., & Guguen-Guillouzo, C. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.2.505 · Cited by 93
Brooks, A. R., Blackhart, B. D., Haubold, K., & Levy-Wilson, B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89527-1 · Cited by 92
Naiki, T., Nagaki, M., Shidoji, Y., Kojima, H., Imose, M., Kato, T., Ohishi, N., Yagi, K., & Moriwaki, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105403200 · Cited by 92
Reestablishment of cell polarity of rat hepatocytes in primary culture
Musat, A. I., Sattler, C. A., Sattler, G. L., & Pitot, H. C. (1993) · Hepatology · doi:10.1002/hep.1840180129 · Cited by 92
A shifting paradigm: histone deacetylases and transcriptional activation
Smith, C. L. (2008) · BioEssays · doi:10.1002/bies.20687 · Cited by 91
De Novo Methylation of Nucleosomal DNA by the Mammalian Dnmt1 and Dnmt3A DNA Methyltransferases
Gowher, H., Stockdale, C., Goyal, R., Ferreira, H. C., Owen‐Hughes, T., & Jeltsch, A. (2005) · Biochemistry · doi:10.1021/bi047634t · Cited by 91
Castro, R. E., Ferreira, D. M. S., Zhang, X., Borralho, P. M., Sarver, A. L., Zeng, Y., Steer, C. J., Kren, B. T., & Rodrigues, C. M. P. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00216.2010 · Cited by 91
Micro RNAs: Tiny sequences with enormous potential
Shruti, K., Shrey, K., & Vibha, R. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.058 · Cited by 90
Histone Deacetylases as Transcriptional Activators? Role Reversal in Inducible Gene Regulation
Nusinzon, I., & Horvath, C. M. (2005) · Science's STKE · doi:10.1126/stke.2962005re11 · Cited by 90
Sidhu, J. S., & Omiecinski, C. J. (1995) · Pharmacogenetics · doi:10.1097/00008571-199502000-00003 · Cited by 90 · cited 1×
“cell culture medium (Sidhu and Omiecinski 1995; LeCluyse et al. 1999).”
Transcriptional activators in hepatocytes.
Johnson, P. F. (1990) · PubMed · Cited by 89
Polyelectrolyte Nano-scaffolds for the Design of Layered Cellular Architectures
Rajagopalan, P., Shen, C. J., Francois Berthiaume, B., Tilles, A. W., Toner, M., & Yarmush, M. L. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.1553 · Cited by 89
Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity
Elferink, M. G. L., Olinga, P., Draaisma, A. L., Merema, M. T., Bauerschmidt, S., Polman, J. E. M., Schoonen, W. G. E. J., & Groothuis, G. M. M. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.01.037 · Cited by 89
Jover, R., Moya, M., & Gomez-Lechon, M. (2009) · Current Drug Metabolism · doi:10.2174/138920009788898000 · Cited by 89
Dell, H., & Hadzopoulou-Cladaras, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.9013 · Cited by 88 · cited 1×
“HNF-4a itself is also a target of CBP-mediated acetylation, which enhances its DNA-binding ability (Dell and Hadzopoulou-Cladaras 1999).”
BackgroundObstacles and Opportunities in New Drug Development
Kaitin, K. I. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100462 · Cited by 88
Nishiyori, A., Tashiro, H., Kimura, A., Akagi, K., Yamamura, K., Mori, M., & Takiguchi, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42261-7 · Cited by 86
Skett, P. (1994) · Toxicology in Vitro · doi:10.1016/0887-2333(94)90174-0 · Cited by 86
Kock, J. D., Ceelen, L. M., Spiegelaere, W. D., Casteleyn, C. R., Claes, P., Vanhaecke, T., & Rogiers, V. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0706-1 · Cited by 85
Self-citationLee, Y. H., Alberta, J. A., Gonzalez, F. J., & Waxman, D. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36679-6 · Cited by 84
Cultures with cryopreserved hepatocytes: applicability for studies of enzyme induction
Hengstler, J. G., Ringel, M. T., Biefang, K., Hammel, S., Milbert, U., Gerl, M., Klebach, M., Diener, B., Platt, K. L., Boettger, T., et al. (2000) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00141-6 · Cited by 83
The Role of HNF1α, HNF3γ, and Cyclic AMP in Glucose-6-phosphatase Gene Activation
Lin, B., Morris, D. W., & Chou, J. Y. (1997) · Biochemistry · doi:10.1021/bi9703249 · Cited by 82
One Factor Recognizes the Liver-Specific Enhancers in α 1 -Antitrypsin and Transthyretin Genes
Grayson, D. R., Costa, R. H., Xanthopoulos, K. G., & Darnell, J. E., Jr. (1988) · Science · doi:10.1126/science.3257586 · Cited by 82
Schaeffer, E., Guillou, F., Part, D., & Zakin, M. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49476-3 · Cited by 81
Towards an Extended Functional Hepatocyte In Vitro Culture
Miranda, J. P., Leite, S. B., Muller-Vieira, U., Rodrigues, A., Carrondo, M. J. T., & Alves, P. M. (2009) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2008.0352 · Cited by 81
Sidhu, J. S., Liu, F., & Omiecinski, C. J. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.001 · Cited by 81
The role of early in vivo toxicity testing in drug discovery toxicology
Fielden, M. R., & Kolaja, K. L. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.2.107 · Cited by 81
Ibeanu, G. C., & Goldstein, J. A. (1995) · Biochemistry · doi:10.1021/bi00025a008 · Cited by 79
Exploratory drug safety: A discovery strategy to reduce attrition in development
Bass, A. S., Cartwright, M. E., Mahon, C., Morrison, R. A., Snyder, R. D., McNamara, P., Bradley, P. K., Zhou, Y., & Hunter, J. (2009) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2009.04.194 · Cited by 78 · cited 4×
“cells or tissues, respectively (Bass et al. 2009; Tsaioun et al. 2009).”
BackgroundInfluentialPluripotent stem cell derived hepatocyte like cells and their potential in toxicity screening
Greenhough, S., Medine, C. N., & Hay, D. C. (2010) · Toxicology · doi:10.1016/j.tox.2010.07.012 · Cited by 77
Page, J. L., Johnson, M. C., Olsavsky, K. M., Strom, S. C., Zarbl, H., & Omiecinski, C. J. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm034 · Cited by 76
Delesque-Touchard, N., Park, S.-H., & Waxman, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004027200 · Cited by 75
Prot, J. M., Videau, O., Brochot, C., Legallais, C., Bénech, H., & Leclerc, É. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.054 · Cited by 75
Figueiredo, M. S., & Brownlee, G. G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.20.11828 · Cited by 75
Kotani, N., Maeda, K., Watanabe, T., Hiramatsu, M., Gong, L., Bi, Y., Takezawa, T., Kusuhara, H., & Sugiyama, Y. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.038968 · Cited by 75
Snykers, S., Henkens, T., De Rop, E., Vinken, M., Fraczek, J., De Kock, J., De Prins, E., Geerts, A., Rogiers, V., & Vanhaecke, T. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.009 · Cited by 74
Self-citationLeCluyse, E., Bullock, P., Madan, A., Carroll, K., & Parkinson, A. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15241-5 · Cited by 74
Martinez‐Jimenez, C. P., Gómez-Lechón, M. J., Castell, J. V., & Jover, R. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.008169 · Cited by 73
Schutte, M., Fox, B., Baradez, M.-O., Devonshire, A., Minguez, J., Bokhari, M., Przyborski, S., & Marshall, D. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2011.0371 · Cited by 72
Ishii, Y., Hansen, A. J., & Mackenzie, P. I. (2000) · PubMed · Cited by 72
Mousa, S. A., & Cheresh, D. A. (1997) · Drug Discovery Today · doi:10.1016/s1359-6446(97)01027-1 · Cited by 71
Bierwolf, J., Lutgehetmann, M., Feng, K., Erbes, J., Deichmann, S., Toronyi, E., Stieglitz, C., Nashan, B., Ma, P. X., & Pollok, J. M. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.22924 · Cited by 71
Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins
Bhadriraju, K., & Hansen, L. K. (2000) · Biomaterials · doi:10.1016/s0142-9612(99)00175-1 · Cited by 71
Bois-Joyeux, B., & Danan, J.-L. (1994) · Biochemical Journal · doi:10.1042/bj3010049 · Cited by 70
Induction of the C/EBP Gene by Dexamethasone and Glucagon in Primary-Cultured Rat Hepatocytes
Matsuno, F., Chowdhury, S., Gotoh, T., Iwase, K., Matsuzaki, H., Takatsuki, K., Mori, M., & Takiguchi, M. (1996) · Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021273 · Cited by 70
Signaling Pathways in Liver Diseases
Dufour, J., Trautwein, C., Graf, R., & Clavien, P. (2005) · Springer eBooks · doi:10.1007/b138739 · Cited by 70
Padgham, C. R. W., Boyle, C. C., Wang, X. J., Raleigh, S. M., Wright, M. C., & Paine, A. J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2521 · Cited by 69
Corlu, A., Ilyin, G. P., Cariou, S., Lamy, I., Loyer, P., & Guguen‐Guillouzo, C. (1997) · Cell Biology and Toxicology · doi:10.1023/a:1007475122321 · Cited by 68
Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system
Nakamura, K., Mizutani, R., Sanbe, A., Enosawa, S., Kasahara, M., Nakagawa, A., Ejiri, Y., Murayama, N., Miyamoto, Y., Torii, T., et al. (2010) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2010.08.008 · Cited by 68
Bernard, P., Goudonnet, H., Artur, Y., Desvergne, B., & Wahli, W. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.3.526 · Cited by 67
Chen, D., Lepar, G. J., & KEMPER, B. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37703-7 · Cited by 66
Bisaha, J. G., Simon, T. C., Gordon, J. I., & Breslow, J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19979 · Cited by 66
Gene array analysis and the liver
Shackel, N. A., Gorrell, M. D., & McCaughan, G. W. (2002) · Hepatology · doi:10.1053/jhep.2002.36950 · Cited by 66
Inhibitory Cross-talk between STAT5b and Liver Nuclear Factor HNF3β
Park, S.-H., & Waxman, D. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107597200 · Cited by 66
Deacetylase inhibitors - focus on non-histone targets and effects
Ocker, M. (2010) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v1.i5.55 · Cited by 66
Martínez-Jiménez, C. P., Castell, J. V., Gómez-Lechón, M. J., & Jover, R. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025403 · Cited by 66
Su, T., & Waxman, D. J. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.02.008 · Cited by 64
Purpose-driven biomaterials research in liver-tissue engineering
Ananthanarayanan, A., Narmada, B. C., Mo, X., McMillian, M., & Yu, H. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.10.006 · Cited by 64
Lannoy, V., Decaux, J., Pierreux, C., Lemaigre, F. P., & Rousseau, G. (2002) · Diabetologia · doi:10.1007/s00125-002-0856-z · Cited by 63
Song, C. S., Jung, M. H., Kim, S. C., Hassan, T., Roy, A. K., & Chatterjee, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21856 · Cited by 63
Wade, D. P., Lindahl, G. E., & Lawn, R. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32086-0 · Cited by 62
Mizuguchi, T., Mitaka, T., Hirata, K., Oda, H., & Mochizuki, Y. (1998) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199803)174:3<273::aid-jcp1>3.0.co;2-l · Cited by 62
Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3.
Harnish, D. C., Malik, S., & Karathanasis, S. K. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46917-7 · Cited by 61
Characterization of the 5′-Flanking Region of the Gene for the α Chain of Human Fibrinogen
Hu, C.-H., Harris, J. E., Davie, E. W., & Chung, D. W. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28342 · Cited by 61
Tomomura, A., Sawada, N., Sattler, G. L., Kleinman, H. K., & Pitot, H. C. (1987) · Journal of Cellular Physiology · doi:10.1002/jcp.1041300208 · Cited by 61
Bader, A., Frühauf, N. R., Tiedge, M., Drinkgern, M., Bartolo, L. D., Borlak, J. T., Steinhoff, G., & Haverich, A. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4295 · Cited by 61
Donato, M. T., Castell, J. V., & G�mez-Lech�n, M. J. (1991) · Cell Biology and Toxicology · doi:10.1007/bf00121326 · Cited by 61
Torres-Padilla, M. E., Sladek, F. M., & Weiss, M. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207545200 · Cited by 61
Vinken, M., Henkens, T., Vanhaecke, T., Papeleu, P., Geerts, A., Van Rossen, E., Chipman, J. K., Meda, P., & Rogiers, V. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfj152 · Cited by 61
Self-citationPimental, R. A., Liang, B., Yee, G. K., Wilhelmsson, A., Poellinger, L., & Paulson, K. E. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4365 · Cited by 60
Hepatic Expression of the UGT1A9 Gene Is Governed by Hepatocyte Nuclear Factor 4α
Barbier, O., Girard, H., Inoue, Y., Duez, H., Villeneuve, L., Kamiya, A., Fruchart, J., Guillemette, C., Gonzalez, F. J., & Staels, B. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.003863 · Cited by 60
Activation of signalling pathways during hepatocyte isolation: relevance to toxicology in vitro
Paine, A. J., & Andreakos, E. (2003) · Toxicology in Vitro · doi:10.1016/s0887-2333(03)00146-2 · Cited by 60
Papeleu, P., Loyer, P., Vanhaecke, T., Elaut, G., Geerts, A. E., Guguen‐Guillouzo, C., & Rogiers, V. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00288-5 · Cited by 60
Self-citationLeite, S. B., Teixeira, A. P., Miranda, J. P., Tostões, R. M., Clemente, J. J., Sousa, M. F. Q., Carrondo, M. J. T., & Alves, P. M. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.02.002 · Cited by 60
Functionalized self‐assembling peptide hydrogel enhance maintenance of hepatocyte activity in vitro
Genové, E., Schmitmeier, S., Sala, A., Borrós, S., Bader, A., Griffith, L. G., & Semino, C. E. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00970.x · Cited by 59
Tsutsumi, K., Ito, K., & Ishikawa, K. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.11.4923-4931.1989 · Cited by 58
Martínez-Jiménez, C. P., Gómez-Lechón, M. J., Castell, J. V., & Jover, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604046200 · Cited by 58
Glucagon Receptor Signaling Is Essential for Control of Murine Hepatocyte Survival
Sinclair, E. M., Yusta, B., Streutker, C., Baggio, L. L., Koehler, J. A., Charron, M. J., & Drucker, D. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.075 · Cited by 58
Transcriptional regulation of the CYP2B1 and CYP2B2 genes by C/EBP-related proteins
Luc, P.-V. T., Adesnik, M., Ganguly, S., & Shaw, P. M. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02190-6 · Cited by 57
Drug metabolizing enzymes in rat hepatocytes co-cultured with cell lines
Donato, M. T., Gómez-Lechón, M. J., & Castell, J. V. (1990) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02624440 · Cited by 56
Li, Y., Shen, R. F., Tsai, S. Y., & Woo, S. L. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.10.4362 · Cited by 55
Genomics and proteomics analysis of cultured primary rat hepatocytes
Beigel, J., Fella, K., Kramer, P.-J., Kröger, M., & Hewitt, P. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.06.019 · Cited by 55 · cited 5×
“Indeed, during extended culture periods, progressive loss of the hepatocellular phenotype, both at the morphological and at the functional level, becomes manifested (Beigel et al. 2008; Binda et al. 2003).”
BackgroundInfluentialVanhaecke, T., Henkens, T., Kass, G. E. N., & Rogiers, V. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.022 · Cited by 55
Self-citationRaymondjean, M., Pichard, A., Grégori, C., Ginot, F., & Kahn, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.22.6145 · Cited by 55
Induction and regulation of connexin26 by glucagon in primary cultures of adult rat hepatocytes
Kojima, T., Mitaka, T., Shibata, Y., & Mochizuki, Y. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.8.2771 · Cited by 55
Chung, I., & Bresnick, E. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9815 · Cited by 53
van de Bovenkamp, M., Groothuis, G. M. M., Meijer, D. K. F., & Olinga, P. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.11.019 · Cited by 53
The Polycomb Group Protein SUZ12 regulates histone H3 lysine 9 methylation and HP1α distribution
de la Cruz, C. C., Kirmizis, A., Simon, M. D., Isono, K., Koseki, H., & Panning, B. (2007) · Chromosome Research · doi:10.1007/s10577-007-1126-1 · Cited by 52
Hepatic Stellate Cell-Mediated Three-Dimensional Hepatocyte and Endothelial Cell Triculture Model
Kasuya, J., Sudo, R., Mitaka, T., Ikeda, M., & Tanishita, K. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0033 · Cited by 52
Network Analysis of Primary Hepatocyte Dedifferentiation Using a Shotgun Proteomics Approach
Rowe, C., Goldring, C. E. P., Kitteringham, N. R., Jenkins, R. E., Lane, B. S., Sanderson, C., Elliott, V., Platt, V., Metcalfe, P., & Park, B. K. (2010) · Journal of Proteome Research · doi:10.1021/pr1001687 · Cited by 51
Diffusion in tissue cultures on gas-permeable and impermeable supports
Jensen, M. D., Wallach, D. F. H., & Sherwood, P. J. (1976) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(76)80085-9 · Cited by 51
Transcriptional Regulation of the Human CYP2A6 Gene
Pitarque, M., Rodríguez‐Antona, C., Oscarson, M., & Ingelman‐Sundberg, M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081570 · Cited by 51
Miyazaki, M., Mars, W. M., Runge, D., Kim, T., Bowen, W. C., & Michalopoulos, G. K. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4085 · Cited by 50
Ishii, Y., Hansen, A. J., & Mackenzie, P. I. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26503-2 · Cited by 50
Brooks, A. R., & Levy-Wilson, B. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.3.1134 · Cited by 49
The CYP2B1 Proximal Promoter Contains a Functional C/EBP Regulatory Element
Park, Y., & KEMPER, B. W. (1996) · DNA and Cell Biology · doi:10.1089/dna.1996.15.693 · Cited by 49
Olaharski, A. J., Ji, Z., Woo, J.-Y., Lim, S., Hubbard, A. E., Zhang, L., & Smith, M. T. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl068 · Cited by 49
Yanuka-Kashles, O., Cohen, H., Trus, M., Aran, A. A., Benvenisty, N., & Reshef, L. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7124 · Cited by 48
Nakamura, K., Kato, N., Aizawa, K., Mizutani, R., Yamauchi, J., & Tanoue, A. (2011) · The Journal of Toxicological Sciences · doi:10.2131/jts.36.625 · Cited by 48
Henkens, T., Papeleu, P., Elaut, G., Vinken, M., Rogiers, V., & Vanhaecke, T. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.10.012 · Cited by 48
Self-citationRole of hepatocyte nuclear factor 3γ in the expression of human CYP2C genes
Bort, R., Gómez‐Lechón, M. J., Castell, J. V., & Jover, R. (2004) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.03.032 · Cited by 48
Kienhuis, A. S., Wortelboer, H. M., Maas, W., van Herwijnen, M. H. M., Kleinjans, J. C. S., van Delft, J. H. M., & Stierum, R. H. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.01.010 · Cited by 48
Nakatsuka, H., Sokabe, T., Yamamoto, K., Sato, Y., Hatakeyama, K., Kamiya, A., & Ando, J. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00467.2005 · Cited by 48 · cited 1×
“Moreover, the viability of hepatocytes cultured under high shear conditions is usually lower than that of static controls (Park et al. 2007; Nakatsuka et al. 2006; Powers et al. 2002b; Tanaka et al. 2006).”
BackgroundElaut, G., Török, G., Vinken, M., Laus, G., Papeleu, P., Tourwé, D., & Rogiers, V. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.12.1320 · Cited by 47
Self-citationOgino, M., Nagata, K., Miyata, M., & Yamazoe, Y. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.1012 · Cited by 46
Gotoh, Y., Ishizuka, Y., Matsuura, T., & Niimi, S. (2011) · Biomacromolecules · doi:10.1021/bm101495c · Cited by 45
Liver-specific expression of the human factor VII gene.
Greenberg, D., Miao, C. H., Ho, W., Chung, D. W., & Davie, E. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.26.12347 · Cited by 43
McMillan, J., Shaddock, J. G., Casciano, D. A., Arlotto, M. P., & Leakey, J. E. A. (1991) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(91)90134-a · Cited by 43
Hepatocyte Nuclear Factor 1 Binds to and Transactivates the Human but Not the Rat CYP7A1 Promoter
Chen, J., Cooper, A. D., & Levy-Wilson, B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0980 · Cited by 43
Ourlin, J.-C., Jounaïdi, Y., Maurel, P., & Vilarem, M. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80497-7 · Cited by 42
Williams, C. M., Mehta, G., Peyton, S. R., Zeiger, A. S., Van Vliet, K. J., & Griffith, L. G. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0398 · Cited by 42
Molecular Pathology of Liver Diseases
Nagy, L. E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.08.020 · Cited by 41
Utesch, D., Molitor, E., Platt, K. L., & Oesch, F. (1991) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02630988 · Cited by 41 · cited 1×
“Fibroblasts and fibroblastic cell lines are most commonly used non-hepatic cultivation partners (Donato et al. 1990b; Evenou et al. 2011b; Leite et al. 2011; Sugimachi et al. 2004; Utesch et al. 1991).”
BackgroundLegraverend, C., Eguchi, H., Stroem, A., Lahuna, O., Mode, A., Tollet, P., Westin, S., & Gustafsson, J.-A. (1994) · Biochemistry · doi:10.1021/bi00199a010 · Cited by 39
Cooperative Regulation of CYP2C12 Gene Expression by STAT5 and Liver-specific Factors in Female Rats
Sasaki, Y., Takahashi, Y., Nakayama, K., & Kamataki, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37117 · Cited by 39
Binda, D., Bigot-Lasserre, D., Bonet, A., Thomassin, M., Come, M.-P., Guinchard, C., Bars, R., Jacqueson, A., & Richert, L. (2003) · Toxicology in Vitro · doi:10.1016/s0887-2333(02)00118-2 · Cited by 39
Dannenberg, L. O., Chen, H., Tian, H., & Edenberg, H. J. (2006) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00107.x · Cited by 38 · cited 1×
“DMTI exposure induced the production of the glucose transporter GLUT2 and alcohol dehydrogenases (ADH1B and ADH1C isoforms) in mouse Hepa1c1c7 and human HepG2 cells, respectively (Dannenberg et al. 2006; Jin et al. 2005).”
BackgroundMicrofluidic Platforms for Hepatocyte Cell Culture: New Technologies and Applications
Goral, V. N., & Yuen, P. K. (2011) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0453-8 · Cited by 38
Evenou, F., Hamon, M., Fujii, T., Takeuchi, S., & Sakai, Y. (2011) · Biotechnology Progress · doi:10.1002/btpr.626 · Cited by 38
Kim, Y., Lasher, C. D., Milford, L. M., Murali, T. M., & Rajagopalan, P. (2010) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0012 · Cited by 37 · cited 3×
“Also, the expression of effectors of lipid, amino acid, carbohydrate and bile acid metabolic pathways is higher in hepatocytes cultivated between two layers of collagen, as has been recently demonstrated by genome-wide transcriptional profiling (Kim et al. 2010).”
BackgroundCharacterization of Chemically Induced Hepatotoxicity in Collagen Sandwiches of Rat Hepatocytes
Farkas, D., & Tannenbaum, S. R. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi145 · Cited by 37 · cited 1×
“In addition, an improved constitutive and inducible expression of phase I and II biotransformation enzymes and their upstream transcriptional regulators were also observed (Farkas et al. 2005; Farkas and Tannenbaum 2005; Tuschl and Mueller 2006; Lasher et al. 2011; Kim et al. 2010; Dunn et al. 1991; LeCluyse et al. 19…”
BackgroundMolecular Analysis of the Distal Enhancer of the Mouse α-Fetoprotein Gene
Millonig, J. H., Emerson, J. A., Levorse, J. M., & Tilghman, S. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3848 · Cited by 37
Anatomy of the rat albumin promoter.
Tronche, F., Rollier, A., Herbomel, P., Bach, I., Cereghini, S., Weiss, M. C., & Yaniv, M. (1990) · PubMed · Cited by 36
Cell culture and life support system for microbioreactor and bioassay
Tanaka, Y., Sato, K., Yamato, M., Okano, T., & Kitamori, T. (2005) · Journal of Chromatography A · doi:10.1016/j.chroma.2005.06.053 · Cited by 35
Nuclear Receptors in Drug Metabolism
(2008) · Wiley eBooks · doi:10.1002/9780470409107 · Cited by 34
Nanofabrication of Nonfouling Surfaces for Micropatterning of Cell and Microtissue
Otsuka, H. (2010) · Molecules · doi:10.3390/molecules15085525 · Cited by 34
DNA methylation and demethylation probed by small molecules
Szyf, M. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.09.002 · Cited by 34
Yoshida, Y., Hughes, D. E., Rausa, F. M., Kim, I., Tan, Y., Darlington, G., & Costa, R. H. (2006) · Hepatology · doi:10.1002/hep.21044 · Cited by 34
Isolation and Characterization of the Human UGT2B7 Gene
Carrier, J.-S., Turgeon, D. K., Journault, K., Hum, D. W., & Bélanger, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2795 · Cited by 33
Kojima, T., Yamamoto, M., Tobioka, H., Mizuguchi, T., Mitaka, T., & Mochizuki, Y. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0087 · Cited by 33
Auth, M. K. H., Woitaschek, D., Beste, M., Schreiter, T., Kim, H. S., Oppermann, E., Joplin, R., Baumann, U., Hilgard, P. A., Nadalin, S., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20367 · Cited by 33
The effects of dexamethasone on metabolic activity of hepatocytes in primary monolayer culture
YAMADA, S., Otto, P. S., Kennedy, D. L., & Whayne, T. F. (1980) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02618379 · Cited by 33
Long-Term Function of Cryopreserved Rat Hepatocytes in a Coculture System
Sugimachi, K., Sosef, M. N., Baust, J. M., Fowler, A., Tompkins, R. G., & Toner, M. (2004) · Cell Transplantation · doi:10.3727/000000004773301799 · Cited by 33
Collagen-Gel Cultures of Rat Hepatocytes: Collagen-Gel Sandwich and Immobilization Cultures
Beken, S., Vanhaecke, T., Smet, K. D., Pauwels, M., Vercruysse, A., & Rogiers, V. (2003) · Humana Press eBooks · doi:10.1385/0-89603-519-0:303 · Cited by 33
Self-citationChemical biology of Histone acetyltransferase natural compounds modulators
Piaz, F. D., Vassallo, A., Cuesta‐Rubio, O., Castellano, S., Sbardella, G., & Tommasi, N. D. (2010) · Molecular Diversity · doi:10.1007/s11030-010-9299-5 · Cited by 32
Gardner-Stephen, D. A., & Mackenzie, P. I. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012203 · Cited by 32
Clairmont, A., Ebert, T., Weber, H., Zoidl, C., Eickelmann, P., Schulz, W. A., Sies, H., & Ryffel, G. U. (1994) · PubMed · Cited by 32
Rogiers, V., Akrawi, M., Vercruysse, A., Phillips, I. R., & Shephard, E. A. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0337e.x · Cited by 31
Self-citationBinding and activation of the human aldehyde dehydrogenase 2 promoter by hepatocyte nuclear factor 4
Stewart, M. J., Dipple, K. M., Estonius, M., Nakshatri, H., Everett, L. M., & Crabb, D. W. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00115-8 · Cited by 31
Tissue specific differences in the regulation of the UDP glucuronosyltransferase 2B17 gene promoter
Gregory, P. A., Hansen, A. J., & Mackenzie, P. I. (2000) · Pharmacogenetics · doi:10.1097/00008571-200012000-00006 · Cited by 31
Role of Hepatocyte Nuclear Factors in Transcriptional Regulation of Male-specific CYP2A2
Wiwi, C. A., & Waxman, D. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409294200 · Cited by 31
Höhne, M. W., Becker-Rabbenstein, V., Kahl, G. F., & Taniguchi, H. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81089-7 · Cited by 31
Dohda, T. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh123 · Cited by 31
Nanometric self-assembling peptide layers maintain adult hepatocyte phenotype in sandwich cultures
Wu, J., Marí-Buyé, N., Muiños, T. F., Borrós, S., Favia, P., & Semino, C. E. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-29 · Cited by 31
Yokomori, N., Nishio, K., Aida, K., & Negishi, M. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00048-4 · Cited by 30
CCAAT/enhancer-binding protein-alpha-dependent transactivation of CYP2C12 in rat hepatocytes
Tollet, P., Lahuna, O., Ahlgren, R., Mode, A., & Gustafsson, J. A. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.12.8614413 · Cited by 30
Villa, P., Hockin, L. J., & Paine, A. J. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90139-2 · Cited by 29
Spek, C. A., Lannoy, V. J., Lemaigre, F. P., Rousseau, G. G., Bertina, R. M., & Reitsma, P. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10168 · Cited by 29
Metz, R. P., Auyeung, D. J., Kessler, F. K., & Ritter, J. K. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.319 · Cited by 29
Wang, M., Tan, Y., Costa, R. H., & Holterman, A. L. (2004) · Hepatology · doi:10.1002/hep.20349 · Cited by 28
Zvibel, I., Fiorino, A. S., Brill, S., & Reid, L. M. (1998) · Differentiation · doi:10.1111/j.1432-0436.1998.00215.x · Cited by 27
Liver‐enriched HNF‐3α and ubiquitous factors interact with the human transferrin gene enhancer
Augé‐Gouillou, C., Petropoulos, I., & Zakin, M. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81436-4 · Cited by 27
Nishimura, M., Hagi, M., Ejiri, Y., Kishimoto, S., Horie, T., Narimatsu, S., & Naito, S. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.236 · Cited by 27
HNFl α Activates the Rat UDP Glucuronosyltransferase UGT2B1 Gene Promoter
Hansen, A. J., Lee, Y., Gonzalez, F. J., & Mackenzie, P. I. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.207 · Cited by 27
Transcriptional regulation of the apolipoprotein AI gene
Malik, S. (2003) · Frontiers in bioscience · doi:10.2741/1005 · Cited by 27
Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition
Ommeslaeghe, K. V., Elaut, G., Brecx, V., Papeleu, P., Iterbeke, K., Geerlings, P., Tourwé, D., & Rogiers, V. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00284-1 · Cited by 27
Self-citationLi, N., & Klaassen, C. D. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05653-0 · Cited by 27
Histone deacetylase inhibitors: clinical implications for hematological malignancies
Tambaro, F. P., Dell’Aversana, C., Carafa, V., Nebbioso, A., Radic-Sarikas, B., Ferrara, F., & Altucci, L. (2010) · Clinical Epigenetics · doi:10.1007/s13148-010-0006-2 · Cited by 26
Characterization of the Secreted Proteome of Rat Hepatocytes Cultured in Collagen Sandwiches
Farkas, D., Bhat, V. B., Mandapati, S., Wishnok, J. S., & Tannenbaum, S. R. (2005) · Chemical Research in Toxicology · doi:10.1021/tx0500225 · Cited by 26 · cited 1×
“In addition, an improved constitutive and inducible expression of phase I and II biotransformation enzymes and their upstream transcriptional regulators were also observed (Farkas et al. 2005; Farkas and Tannenbaum 2005; Tuschl and Mueller 2006; Lasher et al. 2011; Kim et al. 2010; Dunn et al. 1991; LeCluyse et al. 19…”
BackgroundElaut, G., Laus, G., Alexandre, E., Richert, L., Bachellier, P., Tourwé, D., Rogiers, V., & Vanhaecke, T. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.116202 · Cited by 26
Self-citationCurrent methodology for the assessment of ADME-Tox properties on drug candidate molecules
Veulens, A. D. L. N., & Rodríguez, R. (2008) · Biotecnología aplicada · Cited by 26
Beken, S., Tytgat, T. O. G., Pahernik, S. A., Koebe, H. G., Vercruysse, A., & Rogiers, V. (1997) · Toxicology in Vitro · doi:10.1016/s0887-2333(97)00088-x · Cited by 25
Self-citationUlvila, J., Arpiainen, S., Pelkonen, O., Aida, K., Sueyoshi, T., Negishi, M., & Hakkola, J. (2004) · Biochemical Journal · doi:10.1042/bj20040387 · Cited by 25
Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?
Doktorova, T. Y., Pauwels, M., Vinken, M., Vanhaecke, T., & Rogiers, V. (2011) · Critical Reviews in Toxicology · doi:10.3109/10408444.2011.623151 · Cited by 25
Self-citationVandenberghe, Y., Foriers, A., Rogiers, V., & Vercruysse, A. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90146-c · Cited by 24
Self-citationVinken, M., Henkens, T., Snykers, S., Lukaszuk, A., Tourwé, D., Rogiers, V., & Vanhaecke, T. (2007) · Toxicology · doi:10.1016/j.tox.2007.04.003 · Cited by 23
Self-citationPapeleu, P., Wullaert, A., Elaut, G., Henkens, T., Vinken, M., Laus, G., Tourwé, D., Beyaert, R., Rogiers, V., & Vanhaecke, T. (2007) · Cell Proliferation · doi:10.1111/j.1365-2184.2007.00466.x · Cited by 23
Self-citationFraczek, J., van Grunsven, L. A., Vinken, M., Sarah, S., Deleu, S., Vanderkerken, K., Vanhaecke, T., & Rogiers, V. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00831.x · Cited by 23
Self-citationAuyeung, D. J., Kessler, F. K., & Ritter, J. K. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9191 · Cited by 23
Müller, A. S., & Pallauf, J. (2003) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/s0946-672x(03)80024-x · Cited by 22
Naiki, T., Nagaki, M., Asano, T., Kimata, T., & Moriwaki, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.102 · Cited by 22
Rogiers, V., Akrawi, M., Vercruysse, A., et al. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20705.x · Cited by 22
Self-citationVandenberghe, Y., Tee, L. B. G., Rogiers, V., & Yeoh, G. C. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81434-n · Cited by 21
Self-citationKim, J. J., Park, B., Kido, Y., & Accili, D. (2001) · Endocrinology · doi:10.1210/endo.142.8.8332 · Cited by 21
Mechanisms controlling growth of hepatocytes in primary culture
Ichihara, A. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01298881 · Cited by 20
cDNA Microarray Analysis in Hepatocyte Differentiation in Huh 7 Cells
Yamashita, Y. I., Shimada, M., Harimoto, N., Tanaka, S., Shirabe, K., Ijima, H., Nakazawa, K., Fukuda, J., Funatsu, K., & Maehara, Y. (2004) · Cell Transplantation · doi:10.3727/000000004783983396 · Cited by 20
De-Risking Drug Discovery with ADDME — A voiding D rug D evelopment M istakes E arly
Tsaioun, K., & Jacewicz, M. S. (2009) · Alternatives to Laboratory Animals · doi:10.1177/026119290903701s10 · Cited by 19
Naiki, T., Nagaki, M., Shidoji, Y., Kojima, H., & Moriwaki, H. (2004) · Cell Transplantation · doi:10.3727/000000004783983855 · Cited by 19
Effect of Trichostatin A on miRNA expression in cultures of primary rat hepatocytes
Bolleyn, J., Fraczek, J., Vinken, M., Lizárraga, D., Gaj, S., van Delft, J. H. M., Rogiers, V., & Vanhaecke, T. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.04.013 · Cited by 19
Self-citationTime for a consistent approach to preparing and culturing hepatocytes?
Skett, P., & Bayliss, M. K. (1996) · Xenobiotica · doi:10.3109/00498259609046683 · Cited by 19
Tissue-Specific and De Novo Promoter Methylation of the Mouse Glucose Transporter 2
Jin, B., Seong, J. K., & Ryu, D. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.2054 · Cited by 18
Donato, M. T., Castell, J. V., & Gómez-Lechón, M. J. (1990) · Toxicology in Vitro · doi:10.1016/0887-2333(90)90101-x · Cited by 18
Cultured rat hepatocytes upregulate Akt and ERK in an ErbB-2-dependent manner
Scheving, L. A., Stevenson, M. C., Zhang, X., & Russell, W. E. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00597.2007 · Cited by 18 · cited 1×
“Nanomolar concentrations of dexamethasone (25–100 nM) are typically used to preserve hepatocytic functions, such as responsiveness to CYP inducers, and to suppress cell proliferation induced by growth factors, such as EGF (Scheving et al. 2008).”
BackgroundNakamura, T., Mura, T., Saito, K., Ohsawa, T., Akiyoshi, H., & Sato, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9797 · Cited by 17
Culture of porcine hepatocytes or bile duct epithelial cells by inductive serum-free media
Caperna, T. J., Blomberg, L. A., Garrett, W. M., & Talbot, N. C. (2011) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-010-9382-3 · Cited by 17
Vind, C., Dich, J., & Grunnet, N. (1989) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(89)90358-5 · Cited by 16
Evenou, F., Couderc, S., Kim, B., Fujii, T., & Sakai, Y. (2011) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/092050610x513242 · Cited by 16
Beken, S., Pauwels, M., Pahernik, S. A., Koebe, H. G., Vercruysse, A., & Rogiers, V. (1997) · Toxicology in Vitro · doi:10.1016/s0887-2333(97)00036-2 · Cited by 16
Self-citationIdentification of functional regulatory regions of the connexin32 gene promoter
Field, J. M. L., Tate, L. A., Chipman, J. K., & Minchin, S. D. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(03)00111-8 · Cited by 16
Research works printed but not linked: 1
- Nishimura M, Ejiri Y, Kishimoto S, Suzuki S, Satoh T, Horie T, Narimatsu S, Naito S (2011) Expression levels of drug-metabolizing enzyme, transporter, and nuclear receptor mRNAs in a novel three-dimensional culture system for human hepatocytes using micro-space plates. Drug Metab Pharmacokinet 26(2):137–144 · DOI
Cited by
McGill, M. R., & Jaeschke, H. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1007-6 · Cited by 704
“Phenobarbital), can be added to the culture medium (171,174,175).”
A liver-on-a-chip platform with bioprinted hepatic spheroids
Bhise, N. S., Manoharan, V., Massa, S., Tamayol, A., Ghaderi, M., Miscuglio, M., Lang, Q., Shrike Zhang, Y., Shin, S. R., Calzone, G., et al. (2016) · Biofabrication · doi:10.1088/1758-5090/8/1/014101 · Cited by 615
Maturation of Induced Pluripotent Stem Cell Derived Hepatocytes by 3D-Culture
Gieseck III, R. L., Hannan, N. R. F., Bort, R., Hanley, N. A., Drake, R. A. L., Cameron, G. W. W., Wynn, T. A., & Vallier, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086372 · Cited by 197
“This is suggestive of contact-dependent apoptosis similar to that seen in low density PHH dedifferentiation [1,2].”
Engineering a perfusable 3D human liver platform from iPS cells
Schepers, A., Li, C., Chhabra, A., Seney, B. T., & Bhatia, S. (2016) · Lab on a Chip · doi:10.1039/c6lc00598e · Cited by 176
Heslop, J. A., Rowe, C., Walsh, J., Sison-Young, R., Jenkins, R., Kamalian, L., Kia, R., Hay, D., Jones, R. P., Malik, H. Z., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-016-1694-y · Cited by 141
“Furthermore, following isolation, primary human hepatocytes undergo a rapid dedifferentiation process in which many unique hepatocyte characteristics are lost, reducing the physiological relevance of the model (Fraczek et al. 2013; Godoy et al. 2013).”
BackgroundInfluential
Metadata
- Authors
- Fraczek, J., Bolleyn, J., Vanhaecke, T., Rogiers, V., & Vinken, M.
- Affiliations
- Vrije Universiteit Brussel (BE)
- Corresponding author
- Fraczek, J.
- Venue
- Archives of Toxicology
- Published
- 2012-12-15
- Volume
- 87
- Issue
- 4
- Pages
- 577-610
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2018187848
- Cited by
- 119
- References
- 422
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 5 · 2023: 9 · 2022: 10 · 2021: 11 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 7 · 2016: 12 · 2015: 9 · 2014: 14 · 2013: 5
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Archives of Toxicology (publishedVersion)
- PubMed (publishedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- primary hepatocyte culture, hepatocyte dedifferentiation, preclinical safety, drug toxicity, high-throughput screening, alternatives to animal testing, long-term hepatocyte culture
- MeSH terms
- Animals, Animal Testing Alternatives, Cells, Cultured, Drug Evaluation, Preclinical, Humans, Xenobiotics, Apoptosis, Hepatocytes, Mice, Rats, Cell Dedifferentiation, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.